BLUE – bluebird bio, Inc.
bluebird bio, Inc.BLUE
$8.35Name : bluebird bio, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $81,180,544.00
EPSttm : -36
bluebird bio, Inc.
$8.35
1.09%$0.09Float Short %
25.04
Margin Of Safety %
Put/Call OI Ratio
0.08
EPS Next Q Diff
-2.9
EPS Last/This Y
11.41
EPS This/Next Y
16.11
Price
8.31
Target Price
23.98
Analyst Recom
3.2
Performance Q
-13.35
Relative Volume
0.27
Beta
0.7
Ticker: BLUE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | BLUE | 9.18 | 0.08 | 2.05 | 126481 |
| 2024-12-20 | BLUE | 8.49 | 0.08 | 0.02 | 127099 |
| 2024-12-23 | BLUE | 7.61 | 0.08 | 0.02 | 120083 |
| 2024-12-24 | BLUE | 7.96 | 0.08 | 0.23 | 120820 |
| 2024-12-26 | BLUE | 8.62 | 0.08 | 0.19 | 120785 |
| 2024-12-27 | BLUE | 8.75 | 0.08 | 0.34 | 120707 |
| 2024-12-30 | BLUE | 7.86 | 0.08 | 0.17 | 120643 |
| 2024-12-31 | BLUE | 8.34 | 0.08 | 0.33 | 120694 |
| 2025-01-02 | BLUE | 8.71 | 0.08 | 0.26 | 120741 |
| 2025-01-03 | BLUE | 9.18 | 0.08 | 0.13 | 120782 |
| 2025-01-06 | BLUE | 9.94 | 0.08 | 0.07 | 121055 |
| 2025-01-07 | BLUE | 9.06 | 0.08 | 0.29 | 121000 |
| 2025-01-08 | BLUE | 8.46 | 0.08 | 0.00 | 121059 |
| 2025-01-09 | BLUE | 8.46 | 0.08 | 0.00 | 121059 |
| 2025-01-10 | BLUE | 8.49 | 0.08 | 0.44 | 121064 |
| 2025-01-13 | BLUE | 8.5 | 0.08 | 0.03 | 121238 |
| 2025-01-14 | BLUE | 8.03 | 0.08 | 0.00 | 121276 |
| 2025-01-15 | BLUE | 8.29 | 0.08 | 0.21 | 121314 |
| 2025-01-16 | BLUE | 8.3 | 0.08 | 13.13 | 121177 |
| 2025-01-17 | BLUE | 8.35 | 0.08 | 0.21 | 121082 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | BLUE | 9.20 | 60.7 | - | -1.40 |
| 2024-12-20 | BLUE | 8.49 | 60.7 | - | -27.19 |
| 2024-12-23 | BLUE | 7.66 | 63.2 | - | -27.19 |
| 2024-12-24 | BLUE | 7.79 | 63.2 | - | -27.19 |
| 2024-12-26 | BLUE | 8.78 | 63.2 | - | -27.19 |
| 2024-12-27 | BLUE | 8.77 | 63.2 | - | -27.19 |
| 2024-12-30 | BLUE | 7.81 | 63.2 | - | -27.19 |
| 2024-12-31 | BLUE | 8.31 | 63.2 | - | -27.19 |
| 2025-01-02 | BLUE | 8.71 | 63.2 | - | -27.19 |
| 2025-01-03 | BLUE | 9.22 | 63.2 | - | -27.19 |
| 2025-01-06 | BLUE | 9.91 | 63.2 | - | -27.19 |
| 2025-01-07 | BLUE | 9.03 | 63.2 | - | -27.19 |
| 2025-01-08 | BLUE | 8.46 | 63.2 | - | -27.19 |
| 2025-01-09 | BLUE | 8.46 | 63.2 | - | -27.19 |
| 2025-01-10 | BLUE | 8.48 | 63.2 | - | -27.19 |
| 2025-01-13 | BLUE | 8.49 | 63.2 | - | -27.19 |
| 2025-01-14 | BLUE | 8.03 | 63.2 | - | -27.19 |
| 2025-01-15 | BLUE | 8.30 | 63.2 | - | -27.19 |
| 2025-01-16 | BLUE | 8.28 | 63.2 | - | -27.19 |
| 2025-01-17 | BLUE | 8.31 | 63.2 | - | -27.19 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | BLUE | -31.63 | 0 | 1.29 |
| 2024-12-20 | BLUE | -31.63 | 0 | 1.29 |
| 2024-12-23 | BLUE | -33.44 | 0 | 25.71 |
| 2024-12-24 | BLUE | -33.44 | 0 | 25.71 |
| 2024-12-26 | BLUE | -31.27 | 0 | 25.71 |
| 2024-12-27 | BLUE | -31.63 | 0 | 25.71 |
| 2024-12-30 | BLUE | -31.63 | 0 | 25.71 |
| 2024-12-31 | BLUE | -31.63 | 0 | 25.71 |
| 2025-01-02 | BLUE | -30.36 | 0 | 25.71 |
| 2025-01-03 | BLUE | -31.63 | 0 | 25.71 |
| 2025-01-06 | BLUE | -30.46 | 0 | 25.71 |
| 2025-01-07 | BLUE | -30.46 | 0 | 25.71 |
| 2025-01-08 | BLUE | -31.72 | 0 | 25.71 |
| 2025-01-09 | BLUE | -31.72 | 0 | 25.71 |
| 2025-01-10 | BLUE | -31.72 | 0 | 25.71 |
| 2025-01-13 | BLUE | -31.72 | 0 | 25.04 |
| 2025-01-14 | BLUE | -31.72 | 0 | 25.04 |
| 2025-01-15 | BLUE | -31.72 | 0 | 25.04 |
| 2025-01-16 | BLUE | -31.72 | 0 | 25.04 |
| 2025-01-17 | BLUE | -31.72 | 0 | 25.04 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.31
Avg. EPS Est. Current Quarter
-5.75
Avg. EPS Est. Next Quarter
-3.21
Insider Transactions
-31.72
Institutional Transactions
Beta
0.7
Average Sales Estimate Current Quarter
26
Average Sales Estimate Next Quarter
37
Fair Value
Quality Score
10
Growth Score
42
Sentiment Score
4
Actual DrawDown %
99.4
Max Drawdown 5-Year %
-99.5
Target Price
23.98
P/E
Forward P/E
PEG
P/S
1.53
P/B
P/Free Cash Flow
EPS
-35.97
Average EPS Est. Cur. Y
-27.19
EPS Next Y. (Est.)
-11.07
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-551.26
Relative Volume
0.27
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
0.9
EPS 1 30Days Diff
-0.19
EBIT Estimation
bluebird bio, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 375
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.
stock quote shares BLUE – bluebird bio, Inc. Stock Price stock today
news today BLUE – bluebird bio, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BLUE – bluebird bio, Inc. yahoo finance google finance
stock history BLUE – bluebird bio, Inc. invest stock market
stock prices BLUE premarket after hours
ticker BLUE fair value insiders trading